Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges

Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential chall...

Descripción completa

Detalles Bibliográficos
Autores principales: Aurigemma, Cristina, Burzotta, Francesco, Vergallo, Rocco, Farina, Piero, Romagnoli, Enrico, Cangemi, Stefano, Bianchini, Francesco, Nesta, Marialisa, Bruno, Piergiorgio, D'Amario, Domenico, Leone, Antonio Maria, Trani, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194080/
https://www.ncbi.nlm.nih.gov/pubmed/35711347
http://dx.doi.org/10.3389/fcvm.2022.895477
Descripción
Sumario:Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.

Ejemplares similares